Zimmer Biomet Holdings Inc. [NYSE: ZBH] closed the trading session at $134.29 on 06/10/20. The day’s price range saw the stock hit a low of $133.17, while the highest price level was $137.47. The stocks have a year to date performance of -10.28 percent and weekly performance of 3.01 percent. The stock has been moved at -8.47 percent over the last six months. The stock has performed 13.81 percent around the most recent 30 days and changed 20.78 percent over the most recent 3-months.
If compared to the average trading volume of 1.96M shares, ZBH reached to a volume of 1981298 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Here’s what leading stock market gurus have to say about Zimmer Biomet Holdings Inc. [ZBH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZBH shares is $137.58 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZBH stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Zimmer Biomet Holdings Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 28, 2020. The new note on the price target was released on April 09, 2020, representing the official price target for Zimmer Biomet Holdings Inc. stock. Previously, the target price had yet another drop from $189 to $153, while Needham kept a Strong Buy rating on ZBH stock.
The Average True Range (ATR) for Zimmer Biomet Holdings Inc. is set at 4.56, with the Price to Sales ratio for ZBH stock in the period of the last 12 months amounting to 3.56. The Price to Book ratio for the last quarter was 2.33, with the Price to Cash per share for the same quarter was set at 11.78. Price to Free Cash Flow for ZBH in the course of the last twelve months was 20.60 with Quick ratio for the last quarter at 1.00.
ZBH stock trade performance evaluation
Zimmer Biomet Holdings Inc. [ZBH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.01. With this latest performance, ZBH shares gained by 13.81% in over the last four-week period, additionally sinking by -8.47% over the last 6 months – not to mention a rise of 11.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZBH stock in for the last two-week period is set at 64.40, with the RSI for the last a single of trading hit 65.64, and the three-weeks RSI is set at 60.38 for Zimmer Biomet Holdings Inc. [ZBH]. The present Moving Average for the last 50 days of trading for this stock 117.13, while it was recorded at 134.37 for the last single week of trading, and 133.44 for the last 200 days.
Zimmer Biomet Holdings Inc. [ZBH]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Zimmer Biomet Holdings Inc. [ZBH] shares currently have an operating margin of +15.13 and a Gross Margin at +63.98. Zimmer Biomet Holdings Inc.’s Net Margin is presently recorded at +14.18.
Return on Total Capital for ZBH is now 5.88, given the latest momentum, and Return on Invested Capital for the company is 5.80. Return on Equity for this stock inclined to 9.57, with Return on Assets sitting at 4.64. When it comes to the capital structure of this company, Zimmer Biomet Holdings Inc. [ZBH] has a Total Debt to Total Equity ratio set at 68.62. Additionally, ZBH Total Debt to Total Capital is recorded at 40.70, with Total Debt to Total Assets ending up at 34.50. Long-Term Debt to Equity for the company is recorded at 56.00, with the Long-Term Debt to Total Capital now at 33.21.
Reflecting on the efficiency of the workforce at the company, Zimmer Biomet Holdings Inc. [ZBH] managed to generate an average of $56,864 per employee. Receivables Turnover for the company is 6.05 with a Total Asset Turnover recorded at a value of 0.33.Zimmer Biomet Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.70.
Earnings per share (EPS) analysis for Zimmer Biomet Holdings Inc. [ZBH] stock
With the latest financial reports released by the company, Zimmer Biomet Holdings Inc. posted 1.93/share EPS, while the average EPS was predicted by analysts to be reported at 1.91/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 1.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZBH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Zimmer Biomet Holdings Inc. go to 5.33%.
Zimmer Biomet Holdings Inc. [ZBH]: Insider Ownership positions
There are presently around $24,810 million, or 91.40% of ZBH stock, in the hands of institutional investors. The top three institutional holders of ZBH stocks are: VANGUARD GROUP INC with ownership of 16,292,262, which is approximately 2.102% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 15,250,454 shares of the stock with an approximate value of $2.05 billion in ZBH stocks shares; and MASSACHUSETTS FINANCIAL SERVICES CO /MA/, currently with $1.42 billion in ZBH stock with ownership of nearly -0.634% of the company’s market capitalization.
Positions in Zimmer Biomet Holdings Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 379 institutional holders increased their position in Zimmer Biomet Holdings Inc. [NYSE:ZBH] by around 19,732,721 shares. Additionally, 504 investors decreased positions by around 18,230,438 shares, while 177 investors held positions by with 146,989,639 shares. The mentioned changes placed institutional holdings at 184,952,798 shares, according to the latest SEC report filing. ZBH stock had 68 new institutional investments in for a total of 9,618,081 shares, while 160 institutional investors sold positions of 3,964,431 shares during the same period.